Repositori institucional URV
Español Català English
TITLE:
Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma - imarina:9362471

URV's Author/s:Avilés Jurado, Francisco Javier / Benaiges Moragrega, Ester / Ceperuelo Mallafré, Maria Victoria / Fernandez Veledo, Sonia / Gómez Gómez, David / GUAITA ESTERUELAS, SANDRA / Hernandez Masgrau, Victor / Maymo Masip, Elsa / Merma Linares, Carla Vanessa / Terra Barbadora, Ximena / Vendrell Ortega, Juan José
Author, as appears in the article.:Benaiges, Ester; Ceperuelo-Mallafre, Victoria; Guaita, Sandra; Maymo-Masip, Elsa; Madeira, Ana; Gomez, David; Hernandez, Victor; Vilaseca, Isabel; Merma, Carla; Leon, Xavier; Terra, Ximena; Vendrell, Joan; Aviles-Jurado, Francesc Xavier; Fernandez-Veledo, Sonia
Author's mail:david.gomez@urv.cat
victor.hernandez@urv.cat
carlavanessa.merma@urv.cat
elsa.maymo@urv.cat
victoria.ceperuelo@urv.cat
franciscojavier.aviles@urv.cat
carlavanessa.merma@urv.cat
ester.benaiges@estudiants.urv.cat
ester.benaiges@estudiants.urv.cat
sonia.fernandez@urv.cat
ximena.terra@urv.cat
jvortega@iispv.cat
Author identifier:0000-0003-3770-8486
0000-0002-9133-3120
0000-0002-4460-9761
0000-0001-5560-8097
0000-0003-2906-3788
0000-0003-1043-5844
0000-0002-6994-6115
Journal publication year:2024
Publication Type:Journal Publications
APA:Benaiges, Ester; Ceperuelo-Mallafre, Victoria; Guaita, Sandra; Maymo-Masip, Elsa; Madeira, Ana; Gomez, David; Hernandez, Victor; Vilaseca, Isabel; Mer (2024). Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma. Head And Neck-Journal For The Sciences And Specialties Of The Head And Neck, 46(7), 1752-1765. DOI: 10.1002/hed.27651
Papper original source:Head And Neck-Journal For The Sciences And Specialties Of The Head And Neck. 46 (7): 1752-1765
Abstract:Metabolic reprogramming and abnormal glucose metabolism are hallmarks of head and neck squamous cell carcinoma (HNSCC). Certain oncogenes can promote cancer-related metabolic changes, but understanding their crosstalk in HNSCC biology and treatment is essential for identifying predictive biomarkers and developing target therapies.We assessed the value of survivin/BIRC5 as a radioresistance factor potentially modulated by glucose for predicting therapeutic sensitivity and prognosis of HNSCC in a cohort of 32 patients. Additionally, we conducted in vitro experiments to explore the role of survivin/BIRC5 in glucose metabolism concerning radiation response.Tumoral BIRC5 expression is associated with serum glucose and predicts locoregional disease-free survival and lower BIRC5 mRNA levels are associated with better outcomes. Upregulation of BIRC5 by radiation depends on glucose levels and provokes a pro-tumoral and radioresistant phenotype in surviving cells.Survivin/BIRC5 might be independently associated with the risk of recurrence in patients with HNSCC.© 2024 The Authors. Head & Neck published by Wiley Periodicals LLC.
Article's DOI:10.1002/hed.27651
Link to the original source:https://onlinelibrary.wiley.com/doi/10.1002/hed.27651
Papper version:info:eu-repo/semantics/publishedVersion
licence for use:https://creativecommons.org/licenses/by/3.0/es/
Department:Medicina i Cirurgia
Ciències Mèdiques Bàsiques
Bioquímica i Biotecnologia
Licence document URL:https://repositori.urv.cat/ca/proteccio-de-dades/
Thematic Areas:Surgery
Saúde coletiva
Otorhinolaryngology
Odontología
Medicina iii
Medicina ii
Medicina i
Interdisciplinar
General medicine
Farmacia
Engenharias iv
Ciências biológicas iii
Ciências biológicas ii
Ciências biológicas i
Biotecnología
Keywords:Therapeutic target
Survivin
Squamous cell carcinoma of head and neck
Radiotherapy
Radioresistance
Radiation tolerance
Prognosis
Middle aged
Male
Inhibitor of apoptosis proteins
Humans
Hnscc
Head and neck neoplasms
Glucose metabolism
Glucose
Female
Disease-free survival
Cell line, tumor
Carcinoma, squamous cell
Birc5 protein, human
Biomarkers, tumor
Aged
Adult
survivin
radiotherapy
radioresistance
radiation
hnscc
expression
cancer-cells
apoptosis
Entity:Universitat Rovira i Virgili
Record's date:2025-01-08
Search your record at:

Available files
FileDescriptionFormat
DocumentPrincipalDocumentPrincipalapplication/pdf

Information

© 2011 Universitat Rovira i Virgili